Sol-Gel Technologies Ltd.
General ticker "SLGL" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $392.7M (TTM average)
Sol-Gel Technologies Ltd. follows the US Stock Market performance with the rate: 39.2%.
Estimated limits based on current volatility of 8.1%: low 79.25$, high 93.18$
Factors to consider:
- Earnings expected soon, date: 2026-03-11 bmo
- Total employees count: 49 as of 2017
- Current price 662.6% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.38$, 11.17$]
- 2025-12-31 to 2026-12-31 estimated range: [3.17$, 10.36$]
Financial Metrics affecting the SLGL estimates:
- Negative: with PPE of -23.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -5.65 <= 0.01
- Positive: Investing cash flow per share per price, % of 10.86 > -0.63
- Positive: Shareholder equity ratio, % of 80.48 > 64.29
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term SLGL quotes
Long-term SLGL plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $3.88MM | $1.55MM | $11.54MM |
| Operating Expenses | $20.13MM | $30.86MM | $23.55MM |
| Operating Income | $-16.24MM | $-29.30MM | $-12.01MM |
| Non-Operating Income | $1.32MM | $2.07MM | $1.43MM |
| R&D Expense | $12.68MM | $23.54MM | $17.80MM |
| Income(Loss) | $-14.92MM | $-27.24MM | $-10.58MM |
| Profit(Loss)* | $-14.92MM | $-27.24MM | $-10.58MM |
| Stockholders Equity | $42.21MM | $38.64MM | $28.85MM |
| Assets | $46.63MM | $45.29MM | $35.85MM |
| Operating Cash Flow | $-9.48MM | $-17.73MM | $-13.89MM |
| Capital expenditure | $0.17MM | $0.13MM | $0.00MM |
| Investing Cash Flow | $1.70MM | $-9.74MM | $26.69MM |
| Financing Cash Flow | $0.01MM | $21.81MM | $0.00MM |
| Earnings Per Share** | $-0.65 | $-1.01 | $-0.38 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.